Debt-to-equity of Century Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Century Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Century Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 52%, a 45% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Century Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 52% -42% -45% 30 Sep 2025
Q2 2025 66% -23% -26% 30 Jun 2025
Q1 2025 80% -4% -4.7% 31 Mar 2025
Q4 2024 99% +23% +31% 31 Dec 2024
Q3 2024 94% +26% +38% 30 Sep 2024
Q2 2024 89% +28% +45% 30 Jun 2024
Q1 2024 84% +27% +48% 31 Mar 2024
Q4 2023 76% +25% +48% 31 Dec 2023
Q3 2023 68% +30% +78% 30 Sep 2023
Q2 2023 62% +34% +126% 30 Jun 2023
Q1 2023 57% +39% +213% 31 Mar 2023
Q4 2022 51% 31 Dec 2022
Q3 2022 38% 30 Sep 2022
Q2 2022 27% 30 Jun 2022
Q1 2022 18% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.